SCHEMBL14929964

SCHEMBL14929964

CCOC(=O)c1c(N2C=COCC2)sc2c1CCCC2=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.62
LMNA P02545 2/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
HPGD P15428 2/20 0.41
USP2 O75604 1/20 0.41
PKM P14618 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
ALOX12 P18054 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ADRA2A P08913 2/20 0.40
ADRA2B P18089 2/20 0.40
ADRA2C P18825 2/20 0.40
KDM4E B2RXH2 2/20 0.39
KMT2A Q03164 7/20 0.39
GAA P10253 3/20 0.39
MAPT P10636 5/20 0.39
THRB P10828 1/20 0.39
MEN1 O00255 5/20 0.38
NPSR1 Q6W5P4 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14924761 0.83 ALDH1A1 (0.65) ALDH1A1LMNASMN1; SMN2HPGDUSP2
SCHEMBL360530 0.81 ALDH1A1 (0.67) ALDH1A1LMNASMN1; SMN2HPGDUSP2
SCHEMBL10330147 0.78 ALDH1A1 (0.69) ALDH1A1LMNASMN1; SMN2HPGDUSP2
SCHEMBL14076494 0.73 ALDH1A1 (0.65) ALDH1A1LMNASMN1; SMN2HPGDUSP2
SCHEMBL3765154 0.71 ALDH1A1 (0.62) ALDH1A1LMNASMN1; SMN2HPGDUSP2
SCHEMBL3091939 0.71 ALDH1A1 (0.65) ALDH1A1LMNASMN1; SMN2HPGDUSP2
SCHEMBL3922541 0.68 ALDH1A1 (1.00) ALDH1A1LMNASMN1; SMN2HPGDUSP2
SCHEMBL2927596 0.68 ALDH1A1 (0.71) ALDH1A1LMNASMN1; SMN2HPGDUSP2
SCHEMBL3992021 0.66 ALDH1A1 (0.83) ALDH1A1LMNASMN1; SMN2HPGDUSP2
SCHEMBL3915483 0.65 ALDH1A1 (0.82) ALDH1A1LMNASMN1; SMN2HPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130116267-A1 Role of PI3K P110 Delta Signaling in Retroviral Infection and Replication NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116267-A1 Role of PI3K P110 Delta Signaling in Retroviral Infection and Replication PIK3R5, PIK3R4, PIK3R3 ALDH1A1 4867/4885LMNA 3891/4885SMN1; SMN2 3999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.